| Followers | 232 |
| Posts | 26887 |
| Boards Moderated | 0 |
| Alias Born | 01/12/2013 |
Saturday, April 25, 2020 8:01:50 PM
Study-
Your email to JT is further enabling management agenda of ‘how can I get really rich‘. These asses had an opportunity to settle with both Hikma and Ready...they flat out refused! Can I prove they refused? Absolutely....no deal was made! Management could have offered an earlier entry into R-I as bait....they failed...or refused...either way incompetence is the only defining word that accurately describes the lack of settlement.
Management had a bonus scheduled to include protection of IP...? Unclear at this moment, but that’s something I want answered!
I love Vascepa but hate Amarin! Management is absolutely incompetent and that includes JT letting Kennedy drive “strategy”; only mistake after mistake following refusal to litigate ACHOR SPA rescindment. AMARIN was ONLY toting big pharmaceutical First Amendment agenda!!! Only reasons why they didn’t protect AMRN longs, sucking up to BP agenda and attempting to enrich themselves in a clean IP win!
Mistake after mistake...an appeal win odds is less than 25%! Facts are diluted by Judge Du decision and her appeal record of less than 10% reversal.
Consider sending JT a second email.
BB
With 2 very favorable judges then our odds may come around to 60-65% IMO and we won’t know that until the day of oral arguments.
Your email to JT is further enabling management agenda of ‘how can I get really rich‘. These asses had an opportunity to settle with both Hikma and Ready...they flat out refused! Can I prove they refused? Absolutely....no deal was made! Management could have offered an earlier entry into R-I as bait....they failed...or refused...either way incompetence is the only defining word that accurately describes the lack of settlement.
Management had a bonus scheduled to include protection of IP...? Unclear at this moment, but that’s something I want answered!
I love Vascepa but hate Amarin! Management is absolutely incompetent and that includes JT letting Kennedy drive “strategy”; only mistake after mistake following refusal to litigate ACHOR SPA rescindment. AMARIN was ONLY toting big pharmaceutical First Amendment agenda!!! Only reasons why they didn’t protect AMRN longs, sucking up to BP agenda and attempting to enrich themselves in a clean IP win!
Mistake after mistake...an appeal win odds is less than 25%! Facts are diluted by Judge Du decision and her appeal record of less than 10% reversal.
Consider sending JT a second email.
BB
If you're not good at being yourself, then maybe that's being yourself!
Recent AMRN News
- Amarin Highlights New REDUCE-IT Analysis Showing Risk-Weighted ApoB May Improve Cardiovascular Risk Detection (AMRN) • IH Market News • 05/27/2026 03:24:38 PM
- New REDUCE-IT® Analysis Presented at the European Atherosclerosis Society (EAS) Congress 2026 Suggests Risk-Weighted ApoB May Improve Identification of Residual Cardiovascular Risk in Statin-Treated Patients with Hypertriglyceridemia • GlobeNewswire Inc. • 05/27/2026 12:00:00 PM
- Earnings Report Shows Narrowing Losses as Amarin (AMRN) Advances Partner-Led Growth Strategy • IH Market News • 04/29/2026 02:19:17 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 04/29/2026 11:06:34 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/29/2026 11:05:15 AM
- Amarin Reports 2026 First Quarter Financial Results • GlobeNewswire Inc. • 04/29/2026 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/22/2026 09:00:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:02 PM
- Amarin to Report First Quarter 2026 Financial Results and Host Conference Call on April 29, 2026 • GlobeNewswire Inc. • 04/15/2026 12:00:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/10/2026 09:01:34 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/10/2026 09:00:20 PM
- American College of Cardiology (ACC) Scientific Sessions 2026 Underscore the Need for Complementary Therapies Including Icosapent Ethyl (IPE) in Treatment of Elevated Triglycerides and Cardiovascular Risk Reduction • GlobeNewswire Inc. • 04/08/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 08:30:11 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 03/30/2026 09:57:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/27/2026 09:00:07 PM
- Amarin Highlights Guideline Recommended Role of Icosapent Ethyl in Managing Cardiovascular Risk Following Release of Updated 2026 ACC/AHA/Multisociety Dyslipidemia Guideline • GlobeNewswire Inc. • 03/18/2026 12:30:00 PM
- New REDUCE-IT Data in Patients at Extreme Cardiovascular Risk and In Vitro Research on the Mechanistic Effects of Eicosapentaenoic Acid (EPA) on Lipoprotein(a) [Lp(a)] Oxidation to be Presented at the American College of Cardiology’s (ACC) Annual Scienti • GlobeNewswire Inc. • 03/16/2026 12:15:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/02/2026 10:31:01 PM
- Effects of Icosapent Ethyl on Risk and Duration of Hospitalizations and Death in REDUCE-IT® Post Hoc Analysis Published in the European Journal of Preventive Cardiology • GlobeNewswire Inc. • 03/02/2026 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/25/2026 12:05:26 PM
